Integrin Alpha(V)Beta(6) For Diagnosis/Prognosis Of Colorectal Carcinoma - EP2979096

The patent EP2979096 was granted to Universitt Zrich on May 10, 2017. The application was originally filed on Mar 27, 2014 under application number EP14712691A. The patent is currently recorded with a legal status of "Revoked".

EP2979096

UNIVERSITT ZRICH
Application Number
EP14712691A
Filing Date
Mar 27, 2014
Status
Revoked
Jan 4, 2019
Grant Date
May 10, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MERCK PATENTFeb 12, 2018-ADMISSIBLE

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP1754714
DESCRIPTIONUS7150871
INTERNATIONAL-SEARCH-REPORTEP0628820
OPPOSITIONUS2012309018
OPPOSITIONUS8398975
OPPOSITIONWO2008112004
OPPOSITIONWO2010065968

Non-Patent Literature (NPL) Citations (21) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- ARMENTA ET AL., TRENDS IN ANALYTICAL CHEMISTRY, (2008), vol. 27, no. 4-
DESCRIPTION- BERESINI ET AL., CLIN CHEM., (199311), vol. 39, pages 2235 - 41-
DESCRIPTION- BERRY ET AL., CLIN CHEM., (198810), vol. 34, no. 10, pages 2087 - 90-
DESCRIPTION- ELLINGTON; SZOSTAK, NATURE, vol. 346, pages 818 - 822-
DESCRIPTION- HAMWI ET AL., AM J CLIN PATHOL., (200010), vol. 114, no. 4, pages 536 - 43-
DESCRIPTION- KREISIG ET AL., ANAL CHEM., (20110601), vol. 83, no. 11, pages 4281 - 7-
DESCRIPTION- PINI ET AL., J.BIOL. CHEM., (1998), vol. 273, pages 21769 - 21776-
DESCRIPTION- RODRIGUES ET AL., MEM INST OSWALDO CRUZ., (200905), vol. 104, no. 3, pages 434 - 40-
DESCRIPTION- STRICHER ET AL., BIOCHEM J., (20050815), vol. 390, pages 29 - 39-
DESCRIPTION- ZHOU ET AL., J ZHEJIANG UNIV SCI B., (200512), vol. 6, no. 12, pages 1148 - 52-
INTERNATIONAL-SEARCH-REPORT- ARABZADEH AZADEH ET AL, "CELL ADHESION MOLECULES IN COLON CANCER METASTASIS", METASTASIS OF COLORECTAL CANCER SPRINGER, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS SERIES : CANCER METASTASIS-BIOLOGY AND TREATMENT (ISSN 1568-2102(PRINT)), (2010), pages 173 - 203, XP009170874 [A] 1-17 * page 173 - page 179 *
INTERNATIONAL-SEARCH-REPORT- YANG GUANG-YUN ET AL, "Integrin alphavbeta6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver", CANCER SCIENCE, JAPANESE CANCER ASSOCIATION, TOKYO, JP, (20080501), vol. 99, no. 5, doi:10.1111/J.1349-7006.2008.00762.X, ISSN 1347-9032, pages 879 - 887, XP009170851 [A] 1-17 * the whole document *
INTERNATIONAL-SEARCH-REPORT- BATES RICHARD C ET AL, "Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma", JOURNAL OF CLINICAL INVESTIGATION, AMERICAN SOCIETY FOR CLINICAL INVESTIGATION, US, (20050201), vol. 115, no. 2, doi:10.1172/JCI23183, ISSN 0021-9738, pages 339 - 347, XP009170831 [A] 1-17 * the whole document *
INTERNATIONAL-SEARCH-REPORT- BANDYOPADHYAY A ET AL, "Defining the role of integrin [alpha]v[beta]6 in cancer", CURRENT DRUG TARGETS, BENTHAM SCIENCE PUBLISHER, US, (20090101), vol. 10, no. 7, doi:10.2174/138945009788680374, ISSN 1389-4501, pages 645 - 652, XP009170853 [A] 1-17 * the whole document *
OPPOSITION- HORNBECK P, "ENZYME-LINKED IMMUNOSORBENT ASSAYS (ELISA)", Current Protocols in Molecular Biology, (19910000), pages 11.2.1 - 11.2.22, XP008055711-
OPPOSITION- John M. Walker, The Protein Protocols Handbook, 2nd ed., Humana Press, (20020000), ISBN 0-089603-940-4-
OPPOSITION- Malgorzata Barczyk, "Integrins", Cell and Tissue Research, (20100000), vol. 339, pages 269 - 280, XP019781789-
OPPOSITION- Rusling et al., "Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer", NIH Public Access, Author Manuscript, Analyst, (20101206), pages 1 - 31, XP055465266-
OPPOSITION- Jay S Desgrosellier et al., "Integrins in cancer: biological implications and therapeutic opportunities", Nat Rev Cancer, (20100100), vol. 10, no. 1, pages 9 - 22, XP055016659
OPPOSITION- Weis et al, "alphaV Integrins in Angiogenes and Cancer", Cold Spring Harb Perspect Med, (20110000), pages 1 - 14, XP055465301
OPPOSITION- BATES et al., "Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma", J. Clin. Invest., (20050000), vol. 115, pages 339 - 347, XP009170831

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents